US Broker Ratings

Benitec Biopharma Inc. (BNTC) Investor Outlook: Exploring a 56% Upside Potential in the Biotech Sector

Benitec Biopharma Inc. (NASDAQ: BNTC) stands out in the biotechnology landscape as a clinical-stage company with a strategic focus on developing novel genetic medicines. Operating within the healthcare sector, Benitec..

Candel Therapeutics, Inc. (CADL) Stock Analysis: Exploring a 229% Upside Potential with Innovative Cancer Therapies

For investors with an eye on the biotechnology sector, Candel Therapeutics, Inc. (NASDAQ: CADL) presents a compelling opportunity characterized by substantial upside potential. With a staggering 229.15% potential upside based..

Pacific Biosciences of California (PACB) Stock Analysis: Insights on a 24% Potential Upside

Pacific Biosciences of California, Inc. (NASDAQ: PACB) has positioned itself as an intriguing prospect in the healthcare sector, particularly within the medical devices industry. With a focus on resolving genetically..

Compass Therapeutics, Inc. (CMPX) Stock Analysis: Unveiling a 170% Upside Potential in Biotechnology

For investors with a keen eye on the biotechnology sector, Compass Therapeutics, Inc. (NASDAQ: CMPX) presents a compelling opportunity, underscored by a staggering potential upside of 170.63%. As a clinical-stage..

Aura Biosciences, Inc. (AURA): Investor Outlook Highlights a Promising 233.86% Upside Potential

Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology company, is capturing the attention of investors with its innovative approach to cancer treatment and a striking potential upside of 233.86%. With..

Abeona Therapeutics Inc. (ABEO) Stock Analysis: Unveiling a Potential 270.71% Upside in Biotech

Abeona Therapeutics Inc. (NASDAQ: ABEO), a clinical-stage biopharmaceutical company, is generating buzz in the healthcare sector with its focus on innovative gene and cell therapies. Specializing in treatments for life-threatening..

Arcturus Therapeutics Holdings (ARCT) Stock Analysis: Unpacking a Potential 219% Upside in the Biotech Sector

Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT), a promising player in the biotechnology industry, has captured the attention of investors with its significant projected upside potential. Specializing in the development of..

TotalEnergies SE (TTE) Stock Analysis: Exploring a 13.81% Upside with Strong Dividends and Strategic Diversification

TotalEnergies SE (TTE), a French multinational energy giant, represents a compelling opportunity for investors interested in diversifying their portfolios within the oil and gas sector. With a substantial market cap..

Immutep Limited (IMMP) Stock Analysis: Biotechnology Innovator with a 348% Potential Upside

Immutep Limited (NASDAQ: IMMP), the Australian biotechnology firm, is making waves in the healthcare sector with its innovative approach to immunotherapy. The company’s focus is on developing novel Lymphocyte Activation..

Quantum-Si Incorporated (QSI) Stock Analysis: Exploring the Healthcare Innovator’s Growth Potential

Quantum-Si Incorporated (QSI) is making waves in the healthcare sector, with its innovative approach to Next Generation Protein Sequencing (NGPS). Based in Branford, Connecticut, Quantum-Si is positioned at the forefront..

Exxon Mobil (XOM) Stock Analysis: Assessing Its 11.97% Potential Upside Amid a Challenging Market

Exxon Mobil Corporation (NYSE: XOM), a titan in the energy sector, continues to capture investor attention as it navigates the evolving landscape of oil and gas integration. With a current..

Wave Life Sciences Ltd. (WVE) Stock Analysis: Exploring a 154% Upside Potential in Biotechnology

Wave Life Sciences Ltd. (NASDAQ: WVE), a clinical-stage biotechnology company based in Singapore, has caught the attention of investors with its innovative approach to RNA medicines and an impressive potential..

Evolent Health, Inc (EVH) Stock Analysis: Exploring a 101% Potential Upside Amidst Market Challenges

Evolent Health, Inc. (NYSE: EVH) is making waves in the healthcare sector with a compelling proposition for investors, boasting a potential upside of 101.32% based on current analyst ratings. Headquartered..

MiMedx Group, Inc. (MDXG) Stock Analysis: A Biotech Play with 87% Potential Upside

MiMedx Group, Inc. (NASDAQ: MDXG) is drawing significant attention in the biotechnology sector with its innovative approach to healthcare solutions. The company, based in Marietta, Georgia, specializes in developing and..

AdaptHealth Corp. (AHCO) Stock Analysis: Is a 50.86% Potential Upside Worth the Investment?

AdaptHealth Corp. (NASDAQ: AHCO), a key player in the healthcare sector, specializes in the distribution of home medical equipment and related services within the United States. With a market capitalization..

Pulse Biosciences, Inc (PLSE): Investor Outlook with a 26.95% Potential Upside

Pulse Biosciences, Inc (NASDAQ: PLSE), a pioneering force in the healthcare sector, has captured investor attention with its innovative bioelectric medicine technologies. Headquartered in Miami, Florida, the company is making..

Omnicell, Inc. (OMCL) Stock Analysis: Navigating Healthcare Automation with a 49.36% Upside Potential

Omnicell, Inc. (NASDAQ: OMCL), a key player in the healthcare sector, stands at the intersection of technology and medication management. With a market capitalization of $1.35 billion, Omnicell is a..

Aveanna Healthcare Holdings Inc (AVAH) Stock Analysis: Navigating Growth with a 16.8% Revenue Surge

Aveanna Healthcare Holdings Inc (AVAH), a prominent player in the healthcare sector, continues to capture investor attention with its impressive revenue growth of 16.8%. Headquartered in Atlanta, Georgia, Aveanna stands..

Pediatrix Medical Group, Inc. (MD) Stock Analysis: Assessing Its Growth Potential Amidst Healthcare Challenges

Pediatrix Medical Group, Inc. (NYSE: MD) is a prominent player in the healthcare sector, specifically within the medical care facilities industry in the United States. With a market capitalization of..

Travere Therapeutics, Inc. (TVTX) Stock Analysis: A 37% Upside in the Biotech Pipeline

Travere Therapeutics, Inc. (TVTX) stands out in the biotechnology sector, not only for its niche focus on rare kidney and metabolic diseases but also for the promising potential upside of..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds